Expression and clinical significance of miR-34a-5p in lumbar disc herniation

This study measured a small RNA molecule called miR-34a-5p in the blood of 112 patients with lumbar disc herniation (LDH) and 112 healthy controls, finding it was elevated in patients and correlated with worse pain (VAS), worse disability (ODI), higher disc degeneration grade (Pfirrmann), and higher inflammatory markers (TNF-alpha, IL-1beta, IL-6), while correlating negatively with functional JOA score and anti-inflammatory IL-10. In lab experiments on human nucleus pulposus cells, overexpressing this microRNA worsened inflammatory injury and reduced cell viability, an effect that was reversed by knocking it down, and the authors identified a gene called ZBTB20 as its molecular target.

AI summary · from the full text · reviewed by Pukhraj Gaheer, Medical Student, Queen's University before publishing

Why it mattersThis is early-stage translational biology suggesting a possible blood biomarker and molecular pathway for disc degeneration, not yet something that changes how residents evaluate or treat LDH patients today.

Presenting this at rounds? Start here

• ?If a blood biomarker like this were validated, how might it change the threshold for recommending imaging or surgery in patients with suspected LDH?
• ?Could inflammatory pathway markers such as this eventually help identify which LDH patients are more likely to fail conservative management and need earlier intervention?